270 related articles for article (PubMed ID: 33012254)
1. The Effect of Radioactive Iodine Therapy on Ovarian Function and Fertility in Female Thyroid Cancer Patients: A Systematic Review and Meta-Analysis.
Piek MW; Postma EL; van Leeuwaarde R; de Boer JP; Bos AME; Lok C; Stokkel M; Filipe MD; van der Ploeg IMC
Thyroid; 2021 Apr; 31(4):658-668. PubMed ID: 33012254
[No Abstract] [Full Text] [Related]
2. Longitudinal Analysis of the Effect of Radioiodine Therapy on Ovarian Reserve in Females with Differentiated Thyroid Cancer.
van Velsen EFS; Visser WE; van den Berg SAA; Kam BLR; van Ginhoven TM; Massolt ET; Peeters RP
Thyroid; 2020 Apr; 30(4):580-587. PubMed ID: 31928168
[No Abstract] [Full Text] [Related]
3. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors.
Sawka AM; Lakra DC; Lea J; Alshehri B; Tsang RW; Brierley JD; Straus S; Thabane L; Gafni A; Ezzat S; George SR; Goldstein DP
Clin Endocrinol (Oxf); 2008 Sep; 69(3):479-90. PubMed ID: 18284643
[TBL] [Abstract][Full Text] [Related]
4. A Single Radioactive Iodine Treatment Has a Deleterious Effect on Ovarian Reserve in Women with Thyroid Cancer: Results of a Prospective Pilot Study.
Yaish I; Azem F; Gutfeld O; Silman Z; Serebro M; Sharon O; Shefer G; Limor R; Stern N; Tordjman KM
Thyroid; 2018 Apr; 28(4):522-527. PubMed ID: 29466932
[TBL] [Abstract][Full Text] [Related]
5. Decline in anti-Müllerian hormone concentrations following radioactive iodine treatment in women with differentiated thyroid cancer: A systematic review and meta-analysis.
Anagnostis P; Florou P; Bosdou JK; Grimbizis GF; Iakovou I; Kolibianakis EM; Goulis DG
Maturitas; 2021 Jun; 148():40-45. PubMed ID: 34024350
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma.
Nies M; Cantineau AEP; Arts EGJM; van den Berg MH; van Leeuwen FE; Muller Kobold AC; Klein Hesselink MS; Burgerhof JGM; Brouwers AH; van Dam EWCM; Havekes B; van den Heuvel-Eibrink MM; Corssmit EPM; Kremer LCM; Netea-Maier RT; van der Pal HJH; Peeters RP; Plukker JTM; Ronckers CM; van Santen HM; van der Horst-Schrivers ANA; Tissing WJE; Bocca G; van Dulmen-den Broeder E; Links TP
Thyroid; 2020 Aug; 30(8):1169-1176. PubMed ID: 32079487
[No Abstract] [Full Text] [Related]
7. Effects of Radioactive Iodine Therapy on Ovarian Reserve: A Prospective Pilot Study.
Evranos B; Faki S; Polat SB; Bestepe N; Ersoy R; Cakir B
Thyroid; 2018 Dec; 28(12):1702-1707. PubMed ID: 30156472
[No Abstract] [Full Text] [Related]
8. Evaluation of Ovarian Reserve with AMH Level in Patients with Well-Differentiated Thyroid Cancer Receiving Radioactive Iodine Ablation Treatment.
Acıbucu F; Acıbucu DO; Akkar ÖB; Dokmetas HS
Exp Clin Endocrinol Diabetes; 2016 Nov; 124(10):593-596. PubMed ID: 27711957
[No Abstract] [Full Text] [Related]
9. Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.
Barreto MCA; Treistman N; Cavalcante LBCP; Bulzico D; de Andrade FA; Corbo R; Alves Junior PAG; Vaisman F
Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38290210
[TBL] [Abstract][Full Text] [Related]
10. Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer.
Sacks W; Wong RM; Bresee C; Braunstein GD
Thyroid; 2015 Apr; 25(4):377-85. PubMed ID: 25578116
[TBL] [Abstract][Full Text] [Related]
11. Impact on testicular function of a single ablative activity of 3.7 GBq radioactive iodine for differentiated thyroid carcinoma.
Bourcigaux N; Rubino C; Berthaud I; Toubert ME; Donadille B; Leenhardt L; Petrot-Keller I; Brailly-Tabard S; Fromigué J; de Vathaire F; Simon T; Siffroi JP; Schlumberger M; Bouchard P; Christin-Maitre S
Hum Reprod; 2018 Aug; 33(8):1408-1416. PubMed ID: 29912343
[TBL] [Abstract][Full Text] [Related]
12. Anti-Müllerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer.
Giusti M; Mittica M; Comite P; Campana C; Gay S; Mussap M
Endocrine; 2018 Jun; 60(3):516-523. PubMed ID: 29302874
[TBL] [Abstract][Full Text] [Related]
13. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
Scheffel RS; Zanella AB; Dora JM; Maia AL
Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
[TBL] [Abstract][Full Text] [Related]
14. Comparison between the different doses of radioactive iodine ablation prescribed in patients with intermediate-to-high-risk differentiated thyroid cancer.
Iizuka Y; Katagiri T; Ogura K; Mizowaki T
Ann Nucl Med; 2019 Jul; 33(7):495-501. PubMed ID: 30955202
[TBL] [Abstract][Full Text] [Related]
15. Feasibility Study Shows Multicenter, Observational Case-Control Study Is Practicable to Determine Risk of Secondary Breast Cancer in Females With Differentiated Thyroid Carcinoma Given Radioiodine Therapy in Their Childhood or Adolescence; Findings Also Suggest Possible Fertility Impairment in Such Patients.
Drozd V; Schneider R; Platonova T; Panasiuk G; Leonova T; Oculevich N; Shimanskaja I; Vershenya I; Dedovich T; Mitjukova T; Grelle I; Biko J; Reiners C
Front Endocrinol (Lausanne); 2020; 11():567385. PubMed ID: 33193085
[No Abstract] [Full Text] [Related]
16. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment.
Chow SM; Yau S; Lee SH; Leung WM; Law SC
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):992-1000. PubMed ID: 15234032
[TBL] [Abstract][Full Text] [Related]
17. Radioiodine-Induced Salivary Gland Damage Detected by Ultrasonography in Patients Treated for Papillary Thyroid Cancer: Radioactive Iodine Activity and Risk.
Horvath E; Skoknic V; Majlis S; Tala H; Silva C; Castillo E; Whittle C; Niedmann JP; González P
Thyroid; 2020 Nov; 30(11):1646-1655. PubMed ID: 32370663
[No Abstract] [Full Text] [Related]
18. Is radioactive iodine- 131 treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?
Souza MC; Momesso DP; Vaisman F; Vieira Neto L; Martins RA; Corbo R; Vaisman M
Arch Endocrinol Metab; 2016 Feb; 60(1):9-15. PubMed ID: 26222230
[TBL] [Abstract][Full Text] [Related]
19. Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis.
Nappi C; Klain M; Cantoni V; Green R; Piscopo L; Volpe F; Maurea S; Petretta M; Cuocolo A
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1630-1639. PubMed ID: 34820683
[TBL] [Abstract][Full Text] [Related]
20. Severe hyponatremia following radioactive iodine therapy in patients with differentiated thyroid cancer.
Kim SK; Yun GY; Kim KH; Park SK; Choi HY; Ha SK; Park HC
Thyroid; 2014 Apr; 24(4):773-7. PubMed ID: 24093878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
